Showing 1–12 of 36 results

5-Amino-1MQ

FOR PRECLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE.
  • Accelerated lipolysis and fat oxidation without thermogenic effects.
  • Improved mitochondrial efficiency and ATP production.
  • Supports insulin sensitivity and glucose homeostasis.
  • Interest in body recomposition protocols in combination with GLP-1 agonists.
  • Supports NAD+ levels relevant to cellular longevity.

AOD-9604

FOR PRECLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE.
  • Targeted fat loss without IGF-1-mediated growth effects.
  • No effect on blood glucose or insulin sensitivity.
  • Fat reduction is well tolerated in patients with metabolic disorders and diabetes.
  • It supports body recomposition when combined with exercise.
  • Being investigated for cartilage repair (TGA approval in Australia for OA).

ARA 290 (Cibinetide)

FOR PRECLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE.
  • Significant improvement in symptoms of small-fiber neuropathy, including pain and autonomic function.
  • Anti-inflammatory action without immunosuppression.
  • Microvascular endothelial protection and improved tissue perfusion.
  • Neuroprotection in cases of ischemic and diabetic neuropathy.
  • No hematopoietic effects; suitable for long-term use.

BAC Water

9,99 
FOR PRECLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE.
  • Bacteriostatic water for reconstituting lyophilized peptides.
  • A sterile, pyrogen-free solution formulated with water for injection and 0.9% benzyl alcohol as a bacteriostatic preservative.

BC10+TB10+GHK50 (Glow)

119,00 
FOR PRECLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE.
  • Comprehensive tissue regeneration in the musculoskeletal and integumentary systems.
  • GHK-Cu provides systemic anti-aging benefits and supports skin and hair health.
  • Improved synthesis of collagen and the extracellular matrix.
  • Systemic antioxidant and anti-inflammatory protection.
  • Premium full-body restoration protocol with aesthetic and functional benefits.

BPC 157

FOR PRECLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE.
  • Accelerated healing of tendons, ligaments, muscles, and connective tissue.
  • Protection of the gastrointestinal mucosa and support for ulcer healing.
  • Neuroprotection and peripheral nerve regeneration.
  • Powerful anti-inflammatory action through the suppression of pro-inflammatory cytokines.
  • Systemic cytoprotective effects on multiple organ systems.
  • Benefits at SNC: Research on depression, PTSD, and addictive behavior.

BPC 5 mg + TB 5 mg

FOR PRECLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE.
  • Faster soft tissue repair than with any of the peptides alone.
  • Coverage for localized repair (BPC-157) and systemic repair (TB-500).
  • Reduction of inflammation and pain following an injury.
  • Recovery of joints, tendons, ligaments, and muscles.
  • A convenient, single-vial protocol for injury recovery.

CJC-1295 5 mg without DAC + IPA 5 mg

FOR PRECLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE.
  • Synergistic optimization of endogenous GH secretion.
  • Reference GH Peptide Stack for Body Composition.
  • Increased lean body mass, fat loss, and recovery.
  • Maintenance of the pulsatile rhythm of GH, with lower long-term risk.
  • Ipamorelin's selectivity minimizes the increase in cortisol and prolactin.

CJC-1295 with DAC

FOR PRECLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE.
  • Sustained increase in GH and IGF-1 with once-weekly administration.
  • Increased lean muscle mass and improved body composition.
  • Improved fat metabolism, especially visceral fat.
  • Improved sleep quality and recovery.
  • Supports bone density during long-term use.

DSIP

28,95 
FOR PRECLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE.
  • Improved sleep quality, especially deep, slow-wave (delta) sleep.
  • Stress-reducing and anxiolytic effects.
  • Normalization of disrupted sleep patterns.
  • Potential application in opioid/alcohol withdrawal syndrome.
  • Geroprotector: anticancer properties in animal models.

Epithalon

FOR PRECLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE.
  • Telomere elongation and cellular longevity.
  • Epigenetic rejuvenation markers in aged tissues.
  • Normalization of the circadian rhythm through pineal regulation.
  • Cancer Prevention: Tumor-Suppressing Activity in Animal Models.
  • Improved skin elasticity, vision, and neuroendocrine function in longevity studies.
  • One of the most widely studied anti-aging peptides worldwide.

GHK-Cu

FOR PRECLINICAL RESEARCH USE ONLY — NOT APPROVED FOR HUMAN USE.
  • A significant increase in collagen synthesis and improved skin firmness.
  • Accelerated healing and reduced scarring.
  • Stimulation of the hair follicle and improvement in hair density.
  • Systemic anti-aging effect through modulation of gene expression.
  • Systemic antioxidant and anti-inflammatory action.
  • Bone Regeneration and Nerve Repair in Research Models.